Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1994 Jul;49(7):692–694. doi: 10.1136/thx.49.7.692

Value of DNA analysis in addition to cytological testing in the diagnosis of malignant pleural effusions.

F Rodríguez de Castro 1, T Molero 1, O Acosta 1, G Julià-Serdà 1, J Caminero 1, P Cabrera 1, T Carrillo 1
PMCID: PMC475059  PMID: 8066565

Abstract

BACKGROUND--Aneuploidy appears to be a highly specific marker for cancer, and measurement of cellular DNA content by flow cytometry is rapid and reliable. This study was undertaken to determine if the addition of DNA analysis improved the sensitivity of cytological diagnosis of malignancy in pleural fluid. METHODS--Pleural effusions from 92 patients were studied by cytological examination and flow cytometry. RESULTS--In 41 patients the final diagnosis was malignancy, there were 40 cases of benign effusions including 22 with pleural tuberculosis, and in the remaining 11 patients with biopsy proven cancer the presence of malignant cells was not found by cytological and histological means in the pleural fluid. Aneuploidy and cytological malignancy were found in 14 samples. There were seven cases with abnormal flow cytometry and negative cytological results. In 12 patients the cytological test results were positive but DNA analysis was normal. Thirty six samples of fluid were both diploid and cytologically negative. Of the 22 tuberculous effusions seven contained aneuploid cells. The sensitivity of DNA and cytological analysis was 51.2% and 63.4%, respectively. The specificity of DNA analysis was 74.5%. CONCLUSIONS--DNA analysis of cells in malignant pleural effusions is both less sensitive and specific than the cytological diagnosis. Flow cytometric analysis is not recommended for routine use in the diagnosis of pleural effusions.

Full text

PDF
692

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barlogie B., Raber M. N., Schumann J., Johnson T. S., Drewinko B., Swartzendruber D. E., Göhde W., Andreeff M., Freireich E. J. Flow cytometry in clinical cancer research. Cancer Res. 1983 Sep;43(9):3982–3997. [PubMed] [Google Scholar]
  2. Evans D. A., Thornthwaite J. T., Ng A. B., Sugarbaker E. V. DNA flow cytometry of pleural effusions. Comparison with pathology for the diagnosis of malignancy. Anal Quant Cytol. 1983 Mar;5(1):19–27. [PubMed] [Google Scholar]
  3. GRUNZE H. THE COMPARATIVE DIAGNOSTIC ACCURACY, EFFICIENCY AND SPECIFICITY OF CYTOLOGIC TECHNICS USED IN THE DIAGNOSIS OF MALIGNANT NEOPLASM IN SEROUS EFFUSIONS OF THE PLEURAL AND PERICARDIAL CAVITIES. Acta Cytol. 1964 Mar-Apr;8:150–163. [PubMed] [Google Scholar]
  4. Hedley D. W., Philips J., Rugg C. A., Taylor I. W. Measurement of cellular DNA content as an adjunct to diagnostic cytology in malignant effusions. Eur J Cancer Clin Oncol. 1984 Jun;20(6):749–752. doi: 10.1016/0277-5379(84)90211-6. [DOI] [PubMed] [Google Scholar]
  5. Høstmark J., Vigander T., Skaarland E. Characterization of pleural effusions by flow-cytometric DNA analysis. Eur J Respir Dis. 1985 May;66(5):315–319. [PubMed] [Google Scholar]
  6. Katz R. L., Johnson T. S., Williamson K. D. Comparison of cytologic and acridine-orange flow-cytometric detection of malignant cells in human body cavity fluids. Anal Quant Cytol Histol. 1985 Sep;7(3):227–235. [PubMed] [Google Scholar]
  7. MELAMED M. R. The cytological presentation of malignant lymphomas and related diseases in effusions. Cancer. 1963 Apr;16:413–431. doi: 10.1002/1097-0142(196304)16:4<413::aid-cncr2820160402>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  8. Meyer P. C. Metastatic carcinoma of the pleura. Thorax. 1966 Sep;21(5):437–443. doi: 10.1136/thx.21.5.437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Pinto M. M. DNA analysis of malignant effusions. Comparison with cytologic diagnosis and carcinoembryonic antigen content. Anal Quant Cytol Histol. 1992 Jun;14(3):222–226. [PubMed] [Google Scholar]
  10. Schneller J., Eppich E., Greenebaum E., Elequin F., Sherman A., Wersto R., Koss L. G. Flow cytometry and Feulgen cytophotometry in evaluation of effusions. Cancer. 1987 Apr 1;59(7):1307–1313. doi: 10.1002/1097-0142(19870401)59:7<1307::aid-cncr2820590713>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  11. Stonesifer K. J., Xiang J. H., Wilkinson E. J., Benson N. A., Braylan R. C. Flow cytometric analysis and cytopathology of body cavity fluids. Acta Cytol. 1987 Mar-Apr;31(2):125–130. [PubMed] [Google Scholar]
  12. Unger K. M., Raber M., Bedrossian C. W., Stein D. A., Barlogie B. Analysis of pleural effusions using automated flow cytometry. Cancer. 1983 Sep 1;52(5):873–877. doi: 10.1002/1097-0142(19830901)52:5<873::aid-cncr2820520522>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES